drugset / Trial / NCT00788801

Exploratory Positron Emission Tomography (PET) Study to Evaluate the Effects of ABT-614 on [11C]-(+)-PHNO Binding Potential to D3 Receptors in the Brain

NCT00788801 ↗

Phase 1 Completed 11 enrolled Abbott
Non-randomizedSingle-groupOpen-labelBasic science

Summary

This study is being done in healthy volunteers to help researchers understand how ABT-614 works in the human body, specifically in the brain. The PET imaging technique can be thought of as a way to take pictures of chemical changes in the brain. To take a PET scan (picture), a substance with low levels of radioactivity (radiotracer) has to be injected when you are in the PET camera. The radiotracer is only radioactive for a short period of time. In this study, PET is being used to measure how the study drug attaches to specific receptors in the brain. The radiotracer used in this study, \[11C\]-(+)-PHNO, is currently being used for studies in people at the CAMH PET Centre.

Timeline

Start
2008-12
Primary completion
2009-03
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject ABT-614 Unknown — —

Indications

No indication recorded.